Business

GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset

GAITHERSBURG, Md., January 08, 2026--GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset

articleGenedx Holdings Corp.January 8, 20267/company/genedx-holdings-corp/news/genedx-komodo-health-partner-build-133000024
GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset

About this update from Genedx Holdings Corp.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1200,"height":417,"url":"https://media.zenfs.com/en/business-wire.com/1044a1faa19be1bbb39a12265e5f968d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/oO7VRxgbp1F8gfeeApa.oQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMzNDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/1044a1faa19be1bbb39a12265e5f968d","width":960,"height":334},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/zp59SarZu3VzUgmiEly3Ow--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04MzQ7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/1044a1faa19be1bbb39a12265e5f968d","width":1200,"height":417}},"lazy":false},{"type":"text","content":"GeneDx’s Infinity™ will leverage insights from Komodo’s Healthcare Map® to unlock faster health economics and outcomes research (HEOR), biopharma innovation, and AI-driven discovery","length":181,"tagName":"p","attribs":{}},{"type":"text","content":"GAITHERSBURG, Md., January 08, 2026--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a strategic partnership with Komodo Health, the leader in AI-powered healthcare intelligence. Through the partnership, GeneDx’s Infinity™ will leverage real-world patient insights from Komodo’s Healthcare Map®, to create the most comprehensive, longitudinal dataset for rare disease. The collaboration will unlock a new level of visibility into how rare diseases are diagnosed, managed, and treated across the full patient journey.","length":597,"tagName":"p"},{"type":"text","content":"GeneDx Infinity is the world’s largest rare disease genomic dataset, built on more than 25 years of real-world clinical experience. It includes more than 2.5 million genetic tests enriched for rare disease and over 7 million phenotypic data points, with more than half of individuals representing non-European ancestry – making it one of the most diverse and representative rare disease datasets available today. GeneDx Infinity powers the #1 genomic test for rare disease, using world-class clinical interpretation and continuously learning AI to sharpen diagnoses and expand insight with every patient.","length":604,"tagName":"p"},{"type":"text","content":"Komodo’s Healthcare Map is the industry’s most authoritative an...

More updates from Genedx Holdings Corp.

GeneDxrare diseasestrategic partnershipKomodo Healthphenotypic dataKomodo Research DatasetKomodoInfinity